Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advanced MRI Study on Inflammatory and Degenerative Damage in Multiple Sclerosis
2008-007162-32Phase 3Active
- Sponsor
- IRCCS Mondino Foundation
- Start
- Nov 2008
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of interferon beta-1a and glatiramer acetate in multiple sclerosis (MS) (2 arms), sponsored by IRCCS Mondino Foundation. Primary endpoints: Blood-brain barrier permeability, Inflammatory MRI parameters and 1 more. Started Nov 2008; status: active.
02
Drugs
interferon beta-1aglatiramer acetate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2008-007162-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007162-32.